Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes pharmacologic intensificationca-mccqe1ca-ccfpca-rcpsc-im

A 60-year-old man with type 2 diabetes is on metformin at maximum tolerated dose. His HbA1c is 8.2% despite adherence. He is overweight, has established coronary artery disease and an eGFR of 70 mL/min/1.73 m^2. According to Diabetes Canada pharmacologic guidance, which additional medication class is preferred?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.